Clinical Trials Browser

Terminated × Myasthenia Gravis × 90 days × Clear all

NCT06965309 2026-02-12

Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)

Phase NA Terminated

Myasthenia Gravis